OCIAD1 inhibitors belong to a specific class of chemical compounds designed to modulate the activity of OCIAD1, a protein involved in various cellular processes. OCIAD1, or OCIA domain-containing protein 1, is a relatively less understood protein that has garnered attention due to its roles in cellular proliferation, differentiation, and cancer progression. OCIAD1 is thought to be involved in regulating mitochondrial function and intracellular calcium homeostasis, making it an intriguing target for research and development.
The inhibitors within this class typically function by interfering with the activity or expression of OCIAD1. They may act at different levels within the cellular machinery to achieve this modulation. For example, some inhibitors work by directly binding to OCIAD1, disrupting its interaction with other cellular components or affecting its stability. Others may target upstream regulators or pathways that influence OCIAD1 expression or function. These inhibitors can vary widely in their chemical structures and mechanisms of action, reflecting the diverse strategies employed to inhibit OCIAD1.The study of OCIAD1 inhibitors represents an ongoing area of research aimed at deciphering the precise roles of OCIAD1 in cellular physiology and pathology. Understanding the mechanisms of action of these inhibitors and their impact on OCIAD1 function is essential for shedding light on the broader context of cellular processes in which OCIAD1 is implicated. Further research in this field may yield valuable insights into the underlying molecular mechanisms, and serve as tools for OCIAD1 biology and its role in cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid inhibits OCIAID1 by acting as a histone deacetylase (HDAC) inhibitor, leading to increased acetylation of histones. This alteration in chromatin structure results in the re-expression of silenced genes, including OCIAID1, in cancer cells. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is another HDAC inhibitor that affects OCIAID1 expression similarly to vorinostat by promoting histone acetylation and gene reactivation. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat inhibits OCIAID1 through HDAC inhibition, altering gene expression patterns in cancer cells. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is an HDAC inhibitor that modulates OCIAID1 expression by increasing histone acetylation, leading to gene reactivation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is an HDAC inhibitor that affects OCIAID1 expression by promoting histone acetylation, which triggers gene re-expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits OCIAID1 by acting as an HDAC inhibitor, modifying histone acetylation and gene reactivation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is an HDAC inhibitor that modulates OCIAID1 expression through histone acetylation and gene re-expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid inhibits OCIAID1 expression by acting as an HDAC inhibitor, leading to changes in histone acetylation and gene reactivation. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid inhibits OCIAID1 by acting as an HDAC inhibitor, promoting histone acetylation and gene reactivation. | ||||||